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Magnetic nanoparticle (MNP)-based magnetic resonance imaging (MRI) contrast agents (CAs) have been the subject of
extensive research over recent decades. The particle size of MNPs varies widely and is known to influence their
physicochemical and pharmacokinetic properties. There are two commonly used methods for synthesizing MNPs,
organometallic and aqueous solution coprecipitation. The former has the advantage of being able to control the particle
size more effectively; however, the resulting particles require a hydrophilic coating in order to be rendered water soluble.
The MNPs produced using the latter method are intrinsically water soluble, but they have a relatively wide particle size
distribution. Size-controlled water-soluble MNPs have great potential as MRI CAs and in cell sorting and labeling
applications. In the present study, we synthesized CoFe2O4 MNPs using an aqueous solution coprecipitation method.
The MNPs were subsequently separated into four groups depending on size, by the use of centrifugation at different
speeds. The crystal shapes and size distributions of the particles in the four groups were measured and confirmed by
transmission electron microscopy and dynamic light scattering. Using X-ray diffraction analysis, the MNPs were found to
have an inverse spinel structure. Four MNP groups with well-selected semi-Gaussian-like diameter distributions were
obtained, with measured T2 relaxivities (r2) at 4.7 T and room temperature in the range of 60 to 300 mM
−1s−1,
depending on the particle size. This size regulation method has great promise for applications that require
homogeneous-sized MNPs made by an aqueous solution coprecipitation method. Any group of the CoFe2O4 MNPs
could be used as initial base cores of MRI T2 CAs, with almost unique T2 relaxivity owing to size regulation. The
methodology reported here opens up many possibilities for biosensing applications and disease diagnosis.
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Magnetic resonance imaging (MRI) is a powerful diagnostic
modality for noninvasive in vivo imaging due to its high
resolution, lack of exposure to radiation, superior soft tissue
contrast, and large image window. However, it has less sen-
sitivity than nuclear medicine and fluorescence imaging
when monitoring small tissue lesions and molecular or cel-
lular activities [1]. Contrast agents (CAs) can improve the
contrast and specificity in particular target regions of MR* Correspondence: kshong@kbsi.re.kr
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in any medium, provided the original work is pimages, and these are widely used to produce brighter and
darker areas with T1 and T2 CAs, respectively. T2 CAs,
mainly based on iron oxide magnetic nanoparticles
(MNPs), provide dark contrast in T2- or T2*-weighted
(T2*-W) MR images depending on the T2 relaxivity of r2
and the MNP concentration in the region of interest [2].
Superparamagnetic iron oxide (SPIO) nanoparticles with
diameters of 50 to 150 nm are thus the most commonly
used MNPs in a variety of biomedical applications such as
MRI contrast agents, induction of local hyperthermia, ma-
nipulation of cell membranes, biosensors, cell labeling and
tracking, and drug targeting and delivery [3-8].
SPIO particles have different physicochemical and bio-
logical properties, depending on the particle size andOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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beling efficiency [10], cell cytotoxicity [11], and in vivo
pharmacokinetics such as blood half-life and biodistribution
[12]. Therefore, strategies by which uniform-sized biocom-
patible MNPs with long circulation times can be produced
are highly sought after for nanomedical applications.
There are two commonly used methods for synthesiz-
ing MNPs, organometallic [13] and aqueous solution
coprecipitation [14]. In the organometallic approach, the
particle size can be easily controlled [15]; however, the
MNPs are only soluble in nonpolar and moderately polar
organic solvents. This brings about the requirement for
hydrophilic and biocompatible polymer coating to make
them soluble enough for in vivo uses [16-18]. On the
other hand, the aqueous solution coprecipitation method
results in nanoparticles that are intrinsically water-soluble;
however, the particle size distribution is relatively wide,
resulting in nonuniform contrast in T2- or T2*-W MR im-
ages. Size-controlled water-soluble nanoparticles provide
the possibility to achieve uniform functionalization of their
surfaces with other imaging probes such as fluorescent
dyes and radiolabeled probes or with targeting molecules
such as antibodies, peptides, and genes, as well as thera-
peutics [18,19]. Several reports are available regarding the
size regulation of MNPs synthesized by coprecipitation, in-
cluding a temperature-controlled coprecipitation method
that requires specialized equipment and a piezoelectric
nozzle method [20,21]. These processes are either highly
complex or relatively ineffective owing to the require-
ment for a high level of control over parameters such as
temperature during the synthesis. In addition, the pro-
duced particles still have an inadequate size distribution.
The piezoelectric nozzle method is more effective for
controlling the size; however, this technique requires spe-
cialized equipment such as a piezoelectric transducer and a
frequency amplifier.
To address these issues, a facile method for controlling
the MNP core size via the coprecipitation process is intro-
duced here. Initially, we synthesized CoFe2O4 nanoparticles
using an aqueous solution coprecipitation method and
then separated the particles into four groups depending on
their size by employing a variety of centrifugation speeds.
The physicochemical properties of the four groups were
subsequently evaluated. The size distribution was assessed
by transmission electron microscopy (TEM) and dynamic
light scattering (DLS), crystallographic confirmation was
carried out by X-ray diffraction (XRD), the water proton
T2 relaxation rate (R2) versus Co/Fe concentration was
evaluated, and MR image contrast was measured at 4.7 T.
Methods
Synthesis of CoFe2O4 nanoparticles
The CoFe2O4 MNPs were synthesized by an aqueous so-
lution coprecipitation method reported previously [14].Initially, the reagents, 0.5 M FeCl3·6H2O (≥98%; Sigma-
Aldrich, Tokyo, Japan) and 0.25 M CoCl2·6H2O (99% to
102%; Sigma-Aldrich), were mixed in an aqueous solu-
tion, giving a Co/Fe ratio of 1:2. The reaction mixture
was stirred vigorously for 6 h in boiling distilled water
with 1 M NaOH (96%; Junsei, Tokyo, Japan), and then,
the resulting dark brown suspension was centrifuged at
1,771 × g. The precipitate was dissolved in a 2-M HNO3 so-
lution with stirring for 20 min and then centrifuged again
at 1,771 × g. The resulting precipitate was dissolved in
0.5 M Fe(NO3)3 (≥98%; Sigma-Aldrich) and stirred vigor-
ously for 30 min at 100°C. After the reaction, centrifugation
at 1,771 × g and redispersion in distilled water were per-
formed three times. Finally, the suspension was dissolved in
water and stored at room temperature until further use.
Size selection of MNPs and synthesis of SiO2-coated MNPs
As the synthesized MNPs had a broad size distribution
between 5 and 300 nm, they were separated depending on
their size by stepwise centrifugation. A high-speed vacuum
centrifuge system was used (SUPRA 25K; Hanil Scimed,
Gangneung, Korea), with five different speeds of 1,771 × g,
2,767 × g, 11,068 × g, 24,903 × g, and 35,860 × g in order to
separate the synthesized particles into four groups. Firstly,
aggregated particles were removed by down-sinking with
1,771 × g for 1 h. The remaining mixture was centrifuged at
35,860 × g for 1 h, and then, the suspended solution was
removed. Resuspension of the bottom layer provided the
initial MNP solution. This was then centrifuged at 2,767 ×
g, 11,068 × g, and 24,903 × g for 1 h, with the bottom layer
collected as groups A, B, and C, respectively. The first
suspended solution remaining after centrifugation at
24,903 × g was labeled as group D. The MNPs of group C
were selected for SiO2 coating for further applications. SiO2
coating was done as follows: the MNPs of group C
were stabilized with polyvinylpyrrolidone (PVP) to
disperse them homogeneously, and then, tetraethoxysilane
solution was polymerized on the surface of PVP-stabilized
CoF2O4 MNPs by adding ammonia solution as a catalyst
to form SiO2 coating on the MNPs. The volume ratio of
the ammonia solution was 4.2% to control the SiO2 shell
thickness of the final SiO2-coated MNPs in this process.
MNP characterization
The crystal shapes and structures of the synthesized MNPs
in each group, in addition to the SiO2-coated MNPs, were
measured and confirmed by TEM (Tecnai G2 F30, FEI,
Hillsboro, OR, USA) and XRD (XPERT MPD, Philips,
Amsterdam, The Netherlands). The XRD patterns were
compared with a typical XRD spectrum of a CoFe2O4
crystal. The hydrodynamic diameter distribution of the
particles was measured by DLS (UPA-150l, Microtrac,
Montgomeryville, PA, USA), and the size distribution
was verified from the TEM images.
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and the SiO2-coated MNPs, the T2 relaxation times were
measured against the Co/Fe concentration in a range
below 1 mM Fe using a spin-echo pulse sequence (multi-
spin multi-echo) on a 4.7-T animal MRI system (Biospec
47/40; Bruker, Karlsruhe, Germany). The amount of Co/Fe
in each group was measured using an inductively coupled
plasma atomic emission spectrometry system (Optima
4300DV, PerkinElmer, Waltham, MA, USA). For the MRI
experiment, the MNPs were sampled at four different Co/
Fe concentrations of 1.0, 0.75, 0.5, and 0.25 mM Co/Fe in
distilled water in 250-μl microtubes. The MRI parameters
used were as follows: TE/TR = 10/10,000 ms, number of
scans = 2, slice thickness = 1 mm, FOV = 5 × 5 cm2, num-
ber of slices = 1. T2 contrast differences depending on Fe
concentration for the separated groups were also compared
in T2-W MR images.
Results and discussion
The MNPs synthesized by the coprecipitation method were
found to have an extremely broad size distribution [14].
This characteristic would likely result in nonuniform con-
trast in MR images. The purpose of the present study was
to overcome this limitation by separating the different sizes
of particles by centrifugation. After the initial removal ofFigure 1 TEM images of the four MNP groups. The TEM images show t
the group. The mean diameters for the four groups were 24.2 ± 3.6, 20.0 ±aggregates, the nanoparticles were sequentially centrifuged
at speeds 2,767 × g, 11,068 × g, 24,903 × g, and 35,860 × g,
producing groups A, B, C, and D, respectively. As shown in
the TEM images in Figure 1, the centrifugation process
resulted in four groups containing particles relatively
uniform in size. The mean diameters measured from
approximately 100 randomly selected particles from each
group were found to be 24.2 ± 3.6, 20.0 ± 3.6, 15.8 ± 3.6,
and 10.5 ± 2.4 nm for groups A, B, C, and D, respectively.
As the rotational speed increased, the MNP diameters
decreased, with significant differences between adjacent
groups (P < 0.01). The hydrodynamic diameter distribu-
tions of the MNPs in the four groups were Gaussian-like,
with values of 65.5 ± 14.0, 38.9 ± 9.1, 23.1 ± 6.0, and 18.5 ±
4.4 nm (Figure 2a) and volume ratios of 29%, 48%, 13%,
and 10% for groups A to D, respectively. Further, from the
measured volume ratios in Figure 2a, the highest MNP
volume was observed for group B; groups C and D could
also provide an adequate quantity of uniform-sized MNPs
for use in applications that require very small sized
(approximately 10 nm) MNPs. The amount of synthesized
MNPs from group D was approximately 0.5 g, which could
be easily scaled-up using a larger reaction vessel.
The mean diameter of the MNPs, as measured by
TEM and DLS, decreased as the centrifugation speedhat the particles were well dispersed and size-regulated according to
3.6, 15.8 ± 3.6, and 10.5 ± 2.4 nm, for groups a to d, respectively.
Figure 2 Relative size distributions of separated MNP groups and correlation between DLS and TEM results. Relative size distributions of
separated MNP groups in aqueous solution measured by DLS (a) and a graph showing correlation between DLS and TEM results (b). The mean
DLS diameters for the four groups, A to D, were 65.5 ± 14.0, 38.9 ± 9.1, 23.1 ± 6.0, and 18.5 ± 4.4 nm, respectively, with relative volumes of 29%
(A), 49% (B), 12% (C), and 10% (D) as measured by integration of the DLS spectra.
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synthesized by the coprecipitation method were well
separated and clearly resolved into the four groups by the
different centrifugation speeds.
Using the organometallic method reported by others,
the particle size of MNPs can be easily controlled, with
a narrower diameter distribution achievable in compari-
son to the combined coprecipitation and centrifugation
methods described here. However, the amount of MNPs
that can be synthesized in a single process is quite small,
and these have the added disadvantage of being hydro-
phobic. A coating is therefore necessary in order to ren-
der these MNPs hydrophilic and to enable them to be
used for functions such as drug loading, targeting, or
imaging probes (PET or fluorescence). Even though the
size distribution of MNPs synthesized by the coprecipi-
tation method was large, huge amounts of size-controlled
MNPs were obtained by combining the method with aFigure 3 A stack plot of XRD patterns of MNPs and size calculation. The
the typical CoFe2O4 XRD spectrum in which the main peaks are (111), (220), (3
calibrated from signal width for the four groups from A to D were 14.9, 13.2, 12simple centrifugation process. Figure 3a shows the XRD
results obtained for the four groups of CoFe2O4 MNPs. All
groups can be seen to exhibit the same peaks, which match
well with the standard Fe3O4 XRD pattern (JCPDS 75–
0030). The mean particle size (D) can be calculated by the
full-width at half-maximum (FWHM) and the area/height
ratio (β) of the XRD peaks with instrumental correction,
using the equation D = Kλ / β × cosθ, where K is the
Scherrer constant, λ is the wavelength, β is the FWHM (in
radians), and θ is the peak angular position [22,23]. The
XRD information gave crystallite sizes of 14.9, 13.2, 12.1,
and 7.3 nm (Figure 3). As MNPs synthesized by copreci-
pitation may contain some iron oxide crystals, the particle
size calculated from the TEM images was larger than that
from the XRD data (Figure 3b).
The size-dependent MR contrast (T2 relaxivity) of the
MNPs was measured on a 4.7-T MRI system. Figure 4a
shows the dependence of the T2 relaxation rate (R2, s
−1)nanoparticles were well crystallized, and the peaks are in accordance with
11), (400), (511), and (440) (a). The mean diameters of the crystal particles
.1, and 7.3 nm, respectively (b).
Figure 4 Calculated T2 relaxation rates and relaxivity and representative MR image for the four groups. Concentration-dependent T2
relaxation rates (1/T2) (a), calculated T2 relaxivity r2 (b) for the four groups at 4.7 T (200 MHz for protons), and representative MR image (c) for the
four groups depending on the Co/Fe concentration. The slopes of the fitted lines provide the T2 relaxivity (r2) at the concentration of 1 mM for
each group; the values are 302 ± 9, 268 ± 8, 179 ± 5, and 66 ± 4 mM−1s−1 for groups A, B, C, and D, respectively. A representative T2-weighted
MR image (TE/TR = 10/10,000 ms, slice thickness = 2 mm, number of scans = 2), obtained by a conventional spin-echo pulse sequence on a 4.7-T
MRI system, from the samples with four different Co/Fe concentrations (0.25, 0.5, 0.75, and 1.0 mM) for the groups A to D is shown (c). The signal
decrease due to T2 negative contrast is higher with increasing particle size and increasing Co/Fe concentration, especially for group A, which is in
accordance with the result shown in (a).
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was increased with increased Co/Fe concentration, and
the T2 relaxivities (r2) for the groups were measured
from the slopes of the data. The r2 values were found to
be 302 ± 9, 268 ± 8, 179 ± 5, and 66 ± 4 mM−1s−1 for
groups A, B, C, and D, respectively (Figure 4b). These
values are comparable to those in the study of Joshi et al.
[24], in which the T2 relaxivity of cobalt ferrite nanostruc-
tures synthesized by the thermal decomposition method
was reported to be 110 to 301 mM−1s−1 depending on the
particle size (6 to 15 nm). Figure 4c shows an MRI
phantom image with the four groups depending on theFigure 5 TEM images (a) and T2 property measurement (b) of the SiO2-c
CoFe2O4 nanoparticles and a SiO2 coating with a shell thickness of approximat
inset for the particle shape in detail). The measured r2 was 130 ± 2 mM
−1s−1, wCo/Fe concentration measured on the 4.7-T MRI system.
The increase in MR T2 negative contrast was shown to
depend on both the particle diameter and the Co/Fe con-
centration, indicating that a well-controlled contrast with
each size-selected group of MNPs could be obtained. The
particle size dependence of T2 relaxivity was in accordance
with other reports [25,26], in which T2 spin-spin relaxation
is affected by mass magnetization depending on the mag-
netic particle size in the range lower than approximately 1
μm. This demonstrates that each group of MNPs could be
used for specific applications depending on the particle
diameter. One concern regarding these as-prepared MNPsoated MNPs. The TEM images show that the particles consisted of core
ely 25 nm, providing a total particle diameter of 70.8 ± 4.3 nm (note the
hich was 27% smaller than that of the MNP group C core alone.
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problem that needs to be overcome if they are to be
successfully employed in vivo. We therefore investigated
the coating of the MNPs with a stable and biocompatible
material such as SiO2 to enhance stability and avoid poten-
tial toxic effects on cells (Figure 5) [19]. The T2 relaxivity
of the SiO2-coated MNPs made from group C was 130 ± 2
mM−1s−1 (Figure 5b), which was approximately 27% lower
than that of the original core particles. Group C was
selected for SiO2 coating in order to get final SiO2-coated
SPIO MNPs with a diameter of 50 to 100 nm and with
a moderate T2 relaxivity value. The SiO2 coating would
facilitate the addition of therapeutic and targeting func-
tions such as drugs and antibodies to the MNPs, enabling
them to serve as both imaging agents and a therapeutic
carrier species.
There have been several reports on Fe3O4-based MNPs
with a narrow size distribution made by the coprecipitation
method. Lee et al. used a piezoelectric nozzle [20], which,
despite effectively controlling the particle size, requires
specialized equipment and many steps. Jiang et al.
employed a coprecipitation methodology using urea, which
provided SPIO MNPs with a narrow size distribution [27].
The average diameter of these MNPs could be adjusted
from 8 to 50 nm depending on the decomposition of urea
in the ferrite solution; however, they required additional
dextran coating in order to make them water soluble.
In the present study, the use of centrifugation in combin-
ation with the coprecipitation method enabled effective
regulation of the size of the MNPs without the require-
ment for a specialist. A large quantity of each size of parti-
cles could be produced, overcoming many of the
shortcomings of the coprecipitation method.
Conclusions
A simple centrifugation technique was combined with a
coprecipitation method in aqueous solution in order to
obtain four groups of CoFe2O4 MNPs. These were success-
fully produced in large quantities, with different diameters
and MRI T2 relaxivity values and narrow size distributions,
depending on the centrifugation speed. The obtained
MNPs had a strong size-dependent MRI T2 contrast with
T2 relaxivities between 302 and 66 mM
−1s−1, providing a
selection of particles from which the most appropriate for a
specific application could be chosen. In the present study,
the particles of group C were selected for additional SiO2
coating. This was to demonstrate the potential of these
MNPs to be used for in vivo applications where they would
require a long blood half-life, in addition to biocompatibi-
lity. Each of the groups of CoFe2O4 MNPs could be used as
the initial base cores of MRI T2 contrast agents, with
almost unique T2 relaxivity due to the size regulation. This
opens up many possibilities for biosensing applications and
disease diagnosis.Abbreviations
CAs: Contrast agents; DLS: Dynamic light scattering; FWHM: Full-width at
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